Newcore Gold Ltd. (PCR.V) (CVE:PCR – Get Free Report) Director Barry Johnson Blayne purchased 50,000 shares of the firm’s stock in a transaction on Tuesday, December 24th. The stock was bought at an average price of C$0.31 per share, with a total value of C$15,250.00.
Newcore Gold Ltd. (PCR.V) Price Performance
PCR traded up C$0.01 during trading hours on Tuesday, hitting C$0.74. 154,370 shares of the stock were exchanged, compared to its average volume of 222,976. Newcore Gold Ltd. has a 12 month low of C$0.14 and a 12 month high of C$0.86. The stock has a market cap of C$59.16 million and a price-to-earnings ratio of -185.00. The stock has a 50-day simple moving average of C$0.74 and a 200-day simple moving average of C$0.74.
About Newcore Gold Ltd. (PCR.V)
Read More
- Five stocks we like better than Newcore Gold Ltd. (PCR.V)
- Utilities Stocks Explained – How and Why to Invest in Utilities
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- 3 Tickers Leading a Meme Stock Revival
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Newcore Gold Ltd. (PCR.V) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Newcore Gold Ltd. (PCR.V) and related companies with MarketBeat.com's FREE daily email newsletter.